OnKure Therapeutics Inc
OKURBuild a strategy around OKUR
OnKure Therapeutics Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue pre-clinical biotech burning 63.7M TTM cash with 70.3M remaining - roughly 13 months runway at current burn rate.[Cash and Equivalents]
- Trading at 0.5x book value (33.6M market cap vs 66.4M equity) - market pricing high failure probability.[Price to Book Ratio]
- R&D spend of 51.9M TTM is 77% of total opex - heavily weighted toward pipeline vs G&A overhead.[Research and Development]
Watch Triggers
- Cash and Equivalents: Falls below 40M — Triggers emergency financing at distressed terms - 6 month runway threshold.
- Research and Development: Quarterly R&D drops >20% — Signals pipeline deprioritization or cash preservation mode ahead of financing.
- Issuance of Capital Stock: Any equity raise announced — Dilution timing and terms will determine shareholder value preservation.
Bull Case
Deep discount to book (0.5x P/B) means pipeline optionality is essentially free - any clinical success reprices equity significantly.
Clean balance sheet (0.01 D/E, 65.3M working capital) provides flexibility for strategic options without creditor constraints.
Bear Case
13-month runway at current burn guarantees near-term dilution - existing shareholders face 30-50%+ dilution in next financing.
Zero revenue with -90% ROE/ROA indicates value destruction; market cap below cash suggests terminal value concerns.
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage OKUR's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Cash runway exhaustion by mid-2027 will force dilutive financing or partnership.
- 70.3M cash vs 63.7M annual burn
- Zero revenue generation capability
- No debt capacity (0.01 D/E)
Valuation Context
Caveats
OKUR Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$180.97M | — | ||
$-10.73M | — | ||
0.00 | — | ||
$0 | — | ||
$-4.32 | — | ||
0% | — | ||
0% | — | ||
$-50.79M | — | ||
-42.7% | — | ||
Beta 5Y (Monthly) | unknown | — |
OKUR Dividend History
OKUR Stock Splits
OKUR SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
05/05/26 | 03/31/26 | 10-Q | |
03/12/26 | 12/31/25 | Unknown | |
11/06/25 | 09/30/25 | 10-Q | |
08/12/25 | 06/30/25 | 10-Q | |
05/06/25 | 03/31/25 | 10-Q | |
03/10/25 | 12/31/24 | 10-K | |
11/07/24 | 09/30/24 | 10-Q | |
08/26/24 | 06/30/24 | 424B3 | |
06/21/24 | 03/31/24 | S-4 | |
08/26/24 | 12/31/23 | 424B3 | |
11/07/24 | 09/30/23 | 10-Q | |
08/26/24 | 06/30/23 | 424B3 | |
06/21/24 | 03/31/23 | S-4 |